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The gene coding for the inhibitor subunit of the human plasma protein complex inter-u-trypsin inhibitor has been cloned. 
The exon structure of the gene corresponds with the organization of the protein in two distinct inhibitor domains. The 
exons coding for the inhibitor domains each comprise the complete information for a typical Kunitz-type proteinase inhi- 
bitor structure. In contrast to bovine aprotinin, the mature inhibitor protein contains amino acid residues flanking the 
inhibitor domains on both sides. These amino acid residues are encoded by additional exons. 
Exon-intron junction; Kunitz-type structure; Aprotinin; Microglobulin, a,-; Trypsin inhibitor; (Serum, Urine) 
1. INTRODUCTION 
Inter-a-trypsin inhibitor (ITI) [l] is a complex of 
three different types of subunits [2-51. The smallest 
subunit previously called HI30 and thought to be a 
fragment of IT1 carries the inhibitor activity and 
encloses two Kunitz-type inhibitor domains. The 
primary structure of the inhibitor protein is iden- 
tical to that of the so-called serum trypsin inhibitor 
(STI) and urinary trypsin inhibitor (UTI). The in- 
hibitor protein is released from a precursor protein 
composed of ai-microglobulin and the double- 
headed proteinase inhibitor [6]. Only the latter 
becomes part of the protein complex IT1 [2,3]. 
Renal filtration of ST1 leads to the occurrence of 
UT1 in urine. In patients suffering from severe in- 
flammations or cancer large amounts of UT1 can 
be found. This may be due to an increase in biosyn- 
thesis of the precursor protein in an acute phase- 
like response. 
In man, Kunitz-type inhibitor domains have 
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been found recently in a lipoprotein-associated 
coagulation inhibitor [7] and in an amyloid precur- 
sor protein [&lo]. The former protein consists of 
three consecutively linked Kunitz-type inhibitor 
domains, whereas the latter contains only one such 
structural unit. 
In order to obtain information on whether the 
domain structure reflects the structural organiza- 
tion of the gene and how Kunitz-type inhibitor pro- 
teins with multiple domains may have evolved, we 
studied the exon structure of the inhibitor subunit 
gene of human IT1 and compared it to that of the 
bovine aprotinin gene. 
2. MATERIALS AND METHODS 
High-M, DNA was prepared from human leukocytes [l l] and 
partially digested with restriction endonuclease Sau3AI. 
Fragments of 14-24 kb were enriched by centrifugation through 
a sucrose density gradient and used to construct a genomic 
library in EMBL3 h cloning vector as described [12]. 
The genomic library was screened with a cDNA probe cover- 
ing nearly the complete precursor of the inhibitor subunit of 
ITI. DNA of isolated genomic clones was prepared, digested 
with restriction endonucleases and subcloned into plasmid vec- 
tor pTZ18R (Pharmacia). 
Subcloned DNA hybridizing to complete cDNA was se- 
quenced from both ends using the chain termination method 
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F&l. Exon structure of the inhibitor subunit of ITI. Different 
parts of the primary structure of the precursor protein deduced 
from the cDNA are shown in separate boxes termed S (signal 
peptide), M (mature cYi-microglobulin), N, Dl, D2, and C (N- 
terminal peptide, domains 1 and 2, and C-terminal part of the 
mature inhibitor subunit, respectively). 
[13]. Sequence data were collected and analysed using the 
MicroGenieR Sequence Analysis Program, version 5.0 
(Beckman). 
3. RESULTS 
Several clones could be isolated and character- 
ized partially by restriction site mapping of their in- 
serted genomic DNA. Some of these clones were 
found to hybridize selectively with one or both 
oligonucleotides designed for detection of DNA se- 
quences coding for the N-terminal peptide (N, 
fig. 1) of the inhibitor and the 3 ‘-untranslated 
region. DNA of one of these clones contained three 
EcoRI fragments of 0.7, 0.8 and 3.1 kb (fig.1) 
hybridizing to the cDNA. The 3.1 kb DNA frag- 
ment comprises two complete exon sequences, one 
(174 bp) coding for nearly the complete second in- 
hibitor domain, the other (144 bp) for the C- 
terminal part of the second domain as well as the 
3 ‘-untranslated part of the transcript (figs 1,2). 
The smaller EcoRI DNA fragments contain exons 
of 168 and 71-82 bp, coding for the first inhibitor 
domain and the N-terminal peptide of the subunit, 
respectively (figs 1,2). 
4. DISCUSSION 
Most small mammalian proteinase inhibitors 
belong to either the Kazal or the Kunitz family. The 
genomic organization of Kazal-type inhibitor do- 
mains is known to be highly conserved. Coding 
regions of functional domains have been shown to 
be interrrupted by two introns ([ 141 and references 
quoted therein). In the gene of aprotinin, the basic 
bovine pancreatic trypsin inhibitor (BPTI) which is 
considered as the prototype Kunitz proteinase in- 
hibitor, and the gene of a homologous bovine in- 
hibitor, introns do not split the coding region of the 
functional domains [ 15,161. The exon structure of 
the inhibitor subunit gene of IT1 is similar. Se- 
quences coding for the complete conserved cyste- 
ine residue backbone of a typical Kunitz domain 
are flanked by introns (figs l-3). In the case of 
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Fig.2. Primary structure of part of the precursor protein of the inhibitor subunit of ITI. Structural units are labelled as in fig.1. Residues 
which do not appear in the mature proteins are underlined. Regions encoded by distinct exons are separated by vertical lines. Dashed 
vertical lines mark an exon-intron border which cannot yet be defined clearly. 
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aprotinin the complete mature protein is encoded 
by only one exon whereas the mature inhibitor 
subunit of IT1 contains at either side of the in- 
hibitor domains additional amino acid residues 
which are encoded by their own exons. 
The exon/intron junctions conform to the GT- 
AG rule (fig.3). The 5’-end of the exon coding for 
the N-terminal peptide cannot yet be determined 
exactly (fig.3) without knowledge of the 3’-end of 
the preceding exon coding for the C-terminal part 
of cwi-microglobulin. Four AG dinucleotides (fig.3) 
could be discussed as possible 3 ‘-sites of the intron. 
In the case of splicing at the second AG dinucleo- 
tide, the proteolytically fragile linkage -R-V-R-R- 
(figs 2,3) between cui-microglobulin and the in- 
hibitor protein would be encoded by the already 
known exon, and in the case of splicing at the 
fourth AG dinucleotide this linker would be encod- 
ed by an ar-microglobulin exon. Up to now, the 
first arginine residue of the linker sequence is 
regarded as the C-terminal residue of mature 
cui-microglobulin [171. 
According to the classification scheme of Patthy 
[ 181 all exons of the inhibitor subunit of IT1 as well 
as those of aprotinin and its bovine relative are 
symmetrical and of class l-l (fig.3). This means 
that they have introns of the same phase class at 
both their ends. Such nonrandom intron phases are 
preconditions for insertion or duplication 
mechanisms by intronic recombination and a fur- 
ther hint at an evolutionary relationship between 
the representatives of Kunitz-type inhibitors. 
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Fig.3. Exon-intron junctions compared to those of the aprotinin gene. Structural units are labelled as in fig.1. Intron sequences are 
shown in lower case. AC and CT dinucleotides at their ends are boxed. AG dinucleotides which cannot be appointed clearly to an exon- 
intron border are underlined. 
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